Fifth Third Wealth Advisors LLC increased its stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 94.4% in the 3rd quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 8,338 shares of the medical equipment provider's stock after purchasing an additional 4,050 shares during the quarter. Fifth Third Wealth Advisors LLC's holdings in Intuitive Surgical were worth $4,096,000 as of its most recent filing with the SEC.
A number of other institutional investors and hedge funds have also recently added to or reduced their stakes in the stock. International Assets Investment Management LLC increased its holdings in shares of Intuitive Surgical by 49,383.6% during the 3rd quarter. International Assets Investment Management LLC now owns 1,090,619 shares of the medical equipment provider's stock valued at $535,788,000 after acquiring an additional 1,088,415 shares during the last quarter. Capital Research Global Investors bought a new position in shares of Intuitive Surgical in the first quarter valued at approximately $374,390,000. Strategic Financial Concepts LLC lifted its stake in shares of Intuitive Surgical by 40,221.4% in the second quarter. Strategic Financial Concepts LLC now owns 266,121 shares of the medical equipment provider's stock worth $1,184,000 after buying an additional 265,461 shares during the last quarter. Canada Pension Plan Investment Board boosted its holdings in shares of Intuitive Surgical by 36.4% during the 1st quarter. Canada Pension Plan Investment Board now owns 807,780 shares of the medical equipment provider's stock worth $322,377,000 after buying an additional 215,444 shares during the period. Finally, Manning & Napier Advisors LLC acquired a new position in Intuitive Surgical in the 2nd quarter valued at $91,466,000. 83.64% of the stock is owned by hedge funds and other institutional investors.
Several equities analysts recently weighed in on ISRG shares. Truist Financial increased their target price on Intuitive Surgical from $520.00 to $570.00 and gave the company a "buy" rating in a research note on Monday, October 14th. Oppenheimer reaffirmed a "market perform" rating on shares of Intuitive Surgical in a research report on Friday, October 18th. Raymond James boosted their price objective on shares of Intuitive Surgical from $500.00 to $540.00 and gave the stock an "outperform" rating in a report on Monday, October 14th. Piper Sandler restated an "overweight" rating and set a $538.00 price target (up from $495.00) on shares of Intuitive Surgical in a research note on Friday, October 18th. Finally, Redburn Atlantic raised Intuitive Surgical from a "neutral" rating to a "buy" rating and lifted their price objective for the stock from $380.00 to $510.00 in a report on Friday, August 2nd. One investment analyst has rated the stock with a sell rating, five have given a hold rating and thirteen have issued a buy rating to the company's stock. According to MarketBeat.com, the stock currently has a consensus rating of "Moderate Buy" and an average target price of $524.61.
Check Out Our Latest Research Report on Intuitive Surgical
Shares of ISRG opened at $531.64 on Tuesday. The stock has a market cap of $189.36 billion, a P/E ratio of 85.47, a price-to-earnings-growth ratio of 5.19 and a beta of 1.39. The stock's 50-day moving average price is $500.33 and its two-hundred day moving average price is $459.58. Intuitive Surgical, Inc. has a 1 year low of $304.50 and a 1 year high of $544.38.
Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last issued its quarterly earnings data on Thursday, October 17th. The medical equipment provider reported $1.56 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $1.24 by $0.32. The firm had revenue of $2.04 billion during the quarter, compared to analysts' expectations of $2.01 billion. Intuitive Surgical had a net margin of 28.51% and a return on equity of 13.41%. As a group, equities analysts forecast that Intuitive Surgical, Inc. will post 5.45 EPS for the current year.
In other news, Director Amy L. Ladd sold 450 shares of the stock in a transaction dated Friday, September 13th. The shares were sold at an average price of $490.28, for a total transaction of $220,626.00. Following the completion of the transaction, the director now directly owns 821 shares in the company, valued at $402,519.88. This represents a 35.41 % decrease in their position. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. Also, SVP Henry L. Charlton sold 40,243 shares of the company's stock in a transaction dated Friday, August 23rd. The stock was sold at an average price of $486.84, for a total value of $19,591,902.12. Following the sale, the senior vice president now owns 3,001 shares in the company, valued at $1,461,006.84. The trade was a 93.06 % decrease in their position. The disclosure for this sale can be found here. Insiders sold 91,178 shares of company stock valued at $45,897,071 in the last quarter. Company insiders own 0.80% of the company's stock.
Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to [email protected].
Before you consider Intuitive Surgical, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Intuitive Surgical wasn't on the list.
While Intuitive Surgical currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.